Riskpilot← Back to searchSign inGet full accessParatope AB
ABActiveOrg 5591840383Economic activity was not specified by tax authority · NACE 0000Est. 20180 employees
Revenue 2024
SEK 0
EBITDA margin
—
-2100% vs 2023
Equity ratio
99.3%
Financial strength
Net profit 2024
SEK 55,6M
+1852700% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -66K | -2100% |
| Net profit | SEK 55,6M | +1852700% |
| Total assets | SEK 59M | +1374% |
| Equity | SEK 58,5M | +1369% |
| Employees | 0 | — |
Legal name
Paratope AB
Org number
5591840383
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
6 december 2018
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Äga och förvalta fast och lös egendom och därmed förenlig verksamhet. Bolaget ska bedriva konsultverksamhet samt utveckla och marknadsföra metoder, processer och produkter som innefattar tillverkning av antikroppar, proteiner, proteinläkemedel,immunologiska analysmetoder och därmed förenlig verksamhet.
Address
Email
bartek.makower@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −4 | −4 | −3 | −3 | −66 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −4 | −4 | −3 | −3 | −66 |
| Net financials | — | — | — | — | 56 047 |
| Profit before tax | −4 | −4 | −3 | −3 | 55 732 |
| Tax | −0 | −0 | −0 | −0 | −154 |
| Net profit | −4 | −4 | −3 | −3 | 55 578 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 000 | 4 004 | 4 001 | 4 002 | 58 971 |
| Equity | 3 995 | 3 992 | 3 989 | 3 986 | 58 542 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 | 12 | 12 | 16 | 181 |
| Total debt | 5 | 12 | 12 | 16 | 181 |
EBITDA margin
-6600000.0%
This company
15.8%
Market median
-41772252% vs market
20202024
Equity ratio
99.3%
This company
38.2%
Market median
+160% vs market
20202024
Return on equity
94.9%
This company
18.4%
Market median
+416% vs market
20202024
Net profit margin
5557800000.0%
This company
8.1%
Market median
+68614814715% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Paratope AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Åsa Lilly Margareta Makower | Deputy Board Member | 0 companies |
| Bartek Björn Makower | Board of Directors | 0 companies |